The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

All confirmed Omicron cases in EU thus far are asymptomatic or have shown mild symptoms

Tue, 30th Nov 2021 21:49

(Sharecast News) - All confirmed cases of the Omicron variant of concern detected thus far in the European Union had thus far had been either asymptomatic or shown "mild" symptoms, the bloc's pandemic watchdog said.
In an update on the SARS-CoV-2 Omicron variant of concern, the European Centre for Disease Prevention and Control said that 44 cases had been confirmed thus far across 11 EU countries.

For all cases for which information regarding the severity of symptoms was available, those had been either "asymptomatic or had mild symptoms".

"So far, no severe cases or deaths have been reported among these cases," it added.

A majority of the confirmed cases had a history of prior travel to African countries, with some having taken connecting flights at other destinations between Africa and Europe.



Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.